Phase 2 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 55 years old at the time of signing the consent form, of any gender.
- People with a Body Mass Index (BMI) between 27 and 45 kg/m² (a measure of body weight relative to height).
- Male participants with a waist measurement of 90 cm or more, or female participants with a waist measurement of 85 cm or more.
Who may not be able to join:
- People who have any condition that raises the risk of bleeding, such as hemorrhoids, acute gastritis, or stomach/duodenal ulcers.
- People who have a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma) or a related hormonal condition (multiple endocrine neoplasia type 2), or who have an inherited condition that increases the risk of this thyroid cancer.
- People who have a history of pancreas inflammation (pancreatitis) or gallbladder disease with symptoms.
- People whose blood calcitonin level (a hormone marker measured by a blood test) is above the normal range at screening.
- People whose blood pressure at screening is too high — specifically, the top number above 160 or the bottom number above 100 mmHg.
- People whose liver enzyme levels (ALT or AST) are more than twice the upper limit of normal on a blood test at screening.
- People whose fasting blood fat levels are too high — including triglycerides, total cholesterol, or LDL ("bad") cholesterol above specified thresholds at screening.
- People who have abnormally high uric acid levels in their blood along with related physical symptoms (people with high uric acid but no symptoms may still be considered).
- People whose fasting blood sugar level is above 7 mmol/L at screening.
- People whose kidneys are not filtering blood efficiently enough, based on a calculated kidney function score below a certain level at screening (confirm with trial site).
- People who have made significant changes to their diet or exercise habits, or whose body weight has changed by 5% or more, in the 3 months before screening.
- People who have a notable heart rhythm abnormality on an ECG (heart tracing) that the doctor considers a safety concern, or whose ECG shows a specific electrical interval (QTcF) that is too long — above 450 ms for males or above 470 ms for females.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0571-85233836
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.